Patient perceptions, opinions and satisfaction of telehealth with remote blood pressure monitoring postpartum
Thomas et al. BMC Pregnancy and Childbirth
https://doi.org/10.1186/s12884-021-03632-9
(2021) 21:153
ORIGINAL RESEARCH
Open Access
Patient perceptions, opinions and
satisfaction of telehealth with remote blood
pressure monitoring postpartum
Nicole A. Thomas1*, Anna Drewry2, Susan Racine Passmore3, Nadia Assad4 and Kara K. Hoppe2
Abstract
Background: Our aim was to conduct a post participation survey of respondent experiences with in-home remote
patient monitoring via telehealth for blood pressure monitoring of women with postpartum hypertension. We
hypothesized that the in-home remote patient monitoring application will be implemented with strong fidelity and
have positive patient acceptability.
Methods: This analysis was a planned secondary analysis of a non-randomized controlled trial of telehealth with
remote blood pressure patient monitoring for postpartum hypertension compared to standard outpatient
monitoring in women with a hypertension-related diagnosis during pregnancy. In collaboration with survey experts,
we developed a 41-item web-based survey to assess 1) perception of quality of care received, 2) ease of use/ease
to learn the telehealth program, 3) effective orientation of equipment, 4) level of perceived security/privacy utilizing
telehealth and 5) problems encountered. The survey included multiple question formats including Likert scale
responses, dichotomous Yes/No responses, and free text. We performed a descriptive analysis on all responses and
then performed regression analysis on a subset of questions most relevant to the domains of interest. The
qualitative data collected through open ended responses was analyzed to determine relevant categories.
Intervention participants who completed the study received the survey at the 6-week study endpoint.
Results: Sixty six percent of respondents completed the survey. The majority of women found the technology fit
easily into their lifestyle. Privacy concerns were minimal and factors that influenced this included age, BMI, marital
status, and readmissions. 95% of women preferred remote care for postpartum follow-up, in which hypertensive
type, medication use and ethnicity were found to be significant factors in influencing location of follow-up. Most
women were satisfied with the devices, but rates varied by hypertensive type, infant discharge rates and BMI.
Conclusions: Postpartum women perceived the telehealth remote intervention was a safe, easy to use method
that represented an acceptable burden of care and an overall satisfying method for postpartum blood pressure
monitoring.
Trial registration: ClinicalTrials.gov identification number: NCT03111095 Date of registration: April 12, 2017.
Keywords: Postpartum hypertension, Remote patient monitoring, Telehealth, Participant satisfaction, Qualitative
evaluation
* Correspondence:
1
University of Wisconsin-Madison, School of Nursing, Signe Skott Cooper
Hall, 701 Highland Avenue, Madison, WI 53705, USA
Full list of author information is available at the end of the article
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
Thomas et al. BMC Pregnancy and Childbirth
(2021) 21:153
Background
Hypertensive disorders are one of the most common
complications of pregnancy in the United States. Approximately 10% of pregnancies are affected nationwide
[1–3]. While guidelines for antepartum and intrapartum
management of hypertension are numerous, recommendations for monitoring for hypertension in the postpartum period have just started to emerge over the past
decades despite the fact that hypertensive disorders are
one of the leading reasons for postpartum readmission,
morbidity and mortality [3].
Blood pressure (BP) decreases within 48 h following
delivery and increases 3–6 days postpartum [1, 4, 5]. The
American College of Obstetrics and Gynecology
(ACOG) suggests that obstetric providers monitor the
BPs of women with gestational hypertension, preeclampsia or superimposed preeclampsia inpatient, or that
equivalent outpatient surveillance be performed for the
immediate 72 h postpartum and again at 7–10 days postpartum or earlier in women with symptoms [1]. Of note,
50 to 70% of women do not follow up postpartum [6–8].
To address this gap we developed a telehealth with remote monitoring intervention devised for daily home BP
monitoring. All data was transmitted to clinical providers on a daily basis [6]. We conducted a single-site
non-randomized controlled trial of telehealth with remote monitoring and linked interventions for management of postpartum hypertension. The intervention was
associated with reduced hospital readmissions compared
to standard care (1 [0.5%] vs. 8 [3.7%], adjusted relative
risk 0.12; 95% confidence interval (CI): 0.01–0.96) [9].
After providing informed consent, postpartum women
prior to hospital discharge were assigned to and dispensed a remote monitoring unit that securely transmitted individual data to a central monitoring
platform via Bluetooth technology leveraged by Honeywell (now Resideo) Lifestream Clinical Monitoring
solution. To increase equitable utilization of services
among intervention participants, all necessary equipment was provided and telehealth services was capable via wi-fi, internet, or cellular data. Equipment
dispensed to each intervention participant included a
Genesis Touch tablet, automatic blood pressure cuff,
scale and pulse oximeter. Prior to hospital discharge
the participants were trained on use of equipment
and were requested to submit biometric data daily.
Registered nurses trained in the research protocol
assessed participant data daily and used nurse-driven
BP algorithms for initiation, titration and cessation of
anti-hypertensive medication as indicated [6].
ACOG defines telehealth as “technology-enhanced
health care framework that includes services such as
virtual visits, remote patient monitoring, and mobile
health care.” [7] This technology has been used for blood
Page 2 of 11
press (...truncated)